Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
- PMID: 32973815
- PMCID: PMC7461806
- DOI: 10.3389/fimmu.2020.02069
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
Abstract
COVID-19 disease have become so far the most important sanitary crisis in the XXI century. In light of the events, any clinical resource should be considered to alleviate this crisis. Severe COVID-19 cases present a so-called cytokine storm as the most life-threatening symptom accompanied by lung fibrosis. Galectin-3 has been widely described as regulator of both processes. Hereby, we present compelling evidences on the potential role of galectin-3 in COVID-19 in the regulation of the inflammatory response, fibrosis and infection progression. Moreover, we provide a strong rationale of the utility of measuring plasma galectin-3 as a prognosis biomarker for COVID-19 patients and propose that inhibition of galectin-3 represents a feasible and promising new therapeutical approach.
Keywords: COVID-19; biomarker; cytokine storm; fibrosis; galectin-3.
Copyright © 2020 Garcia-Revilla, Deierborg, Venero and Boza-Serrano.
Figures
![FIGURE 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7461806/bin/fimmu-11-02069-g001.gif)
Similar articles
-
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.Signal Transduct Target Ther. 2020 May 29;5(1):84. doi: 10.1038/s41392-020-0191-1. Signal Transduct Target Ther. 2020. PMID: 32467561 Free PMC article. Review.
-
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.Int Arch Allergy Immunol. 2020;181(6):467-475. doi: 10.1159/000508247. Epub 2020 May 11. Int Arch Allergy Immunol. 2020. PMID: 32392562 Free PMC article. Review.
-
Drug targets for COVID-19 therapeutics: Ongoing global efforts.J Biosci. 2020;45(1):87. doi: 10.1007/s12038-020-00067-w. J Biosci. 2020. PMID: 32661214 Free PMC article. Review.
-
COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.Biofactors. 2020 May;46(3):306-308. doi: 10.1002/biof.1633. Epub 2020 Apr 27. Biofactors. 2020. PMID: 32339387 Free PMC article. No abstract available.
-
Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.J Virol. 2020 Oct 14;94(21):e01062-20. doi: 10.1128/JVI.01062-20. Print 2020 Oct 14. J Virol. 2020. PMID: 32788194 Free PMC article.
Cited by
-
Serum Mac-2 binding protein glycosylation isomer and galectin-3 levels in adult-onset Still's disease and their association with cytokines.Front Immunol. 2024 Apr 22;15:1385654. doi: 10.3389/fimmu.2024.1385654. eCollection 2024. Front Immunol. 2024. PMID: 38711500 Free PMC article.
-
Diagnostic Value of Galectin-3 in Exacerbations of Chronic Obstructive Pulmonary Disease.Medicina (Kaunas). 2024 Mar 24;60(4):529. doi: 10.3390/medicina60040529. Medicina (Kaunas). 2024. PMID: 38674175 Free PMC article.
-
The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view.Biomedicines. 2024 Mar 13;12(3):639. doi: 10.3390/biomedicines12030639. Biomedicines. 2024. PMID: 38540252 Free PMC article. Review.
-
Galectin inhibitors and nanoparticles as a novel therapeutic strategy for glioblastoma multiforme.Am J Cancer Res. 2024 Feb 15;14(2):774-795. doi: 10.62347/MKIV1986. eCollection 2024. Am J Cancer Res. 2024. PMID: 38455415 Free PMC article. Review.
-
The Link Between COVID-19 and Alzheimer Disease Through Neuroinflammation.Clin Med Res. 2023 Sep;21(3):119-121. doi: 10.3121/cmr.2023.1841. Clin Med Res. 2023. PMID: 37985172 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases